Lexington, MA, United States of America

Shixin Qin

USPTO Granted Patents = 25 

 

 

Average Co-Inventor Count = 4.1

ph-index = 7

Forward Citations = 134(Granted Patents)


Company Filing History:


Years Active: 2001-2021

Loading Chart...
Loading Chart...
Loading Chart...
25 patents (USPTO):Explore Patents

Title: **Innovative Contributions of Shixin Qin in the Biotech Industry**

Introduction

Shixin Qin, based in Lexington, MA, is an accomplished inventor in the biotech sector, known for his significant contributions to the field of antibody technology. With a remarkable portfolio consisting of 25 patents, Qin has made strides in developing innovative solutions that enhance therapeutic and diagnostic methods.

Latest Patents

Qin's recent patents highlight his dedication to advancing medical science. One of his notable inventions is the development of anti-GCC antibody molecules and related compositions. These antibodies are designed to bind to an extracellular domain of GCC, facilitating internalization into cells. This innovation includes humanized, chimeric, and human antibodies, alongside nucleic acids and vectors encoding these antibodies. The accompanying therapeutic and diagnostic methods open new avenues for cellular targeting in medical treatments.

Additionally, Qin has patented antibodies that bind human CXCR3, once again showcasing his focus on advanced antibody systems. The invention includes compositions comprising the antibodies or antigen-binding fragments and presents therapeutic and diagnostic methods that leverage these antibodies for improved patient outcomes.

Career Highlights

Shixin Qin has had an impactful career, working with Millennium Pharmaceuticals Limited among others in the biotech industry. His expertise in antibody development has been pivotal in the design and creation of targeted therapies, making significant contributions to advancing cancer treatments and other diseases.

Collaborations

Throughout his career, Qin has collaborated with esteemed colleagues, including notable figures such as Walter Newman and Charles R. Mackay. These partnerships have fostered an environment of innovation, leading to the successful development and patenting of groundbreaking technologies in the biotech landscape.

Conclusion

Shixin Qin's work in antibody technologies has paved the way for significant advancements in therapeutic possibilities and diagnostic methods. His innovative spirit continues to inspire professionals in the biotech field, and his numerous patents serve as a testament to his dedication and expertise in transforming healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…